Sustained release of MAPK14 ‐targeting siRNA from polyelectrolyte complex hydrogels mitigates MSC osteogenesis in vitro with potential application in growth plate injury
Journal of Biomedical Materials Research Part A · 2024
DOI: 10.1002/jbm.a.37784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Bikram Adhikari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Biosciences and Bioengineering, Colorado School of Mines, Golden, Colorado, USA. Hauptthemen laut MEDLINE: Hydrogels, Mesenchymal Stem Cells, Osteogenesis, RNA, Small Interfering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NIH HHS, NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The growth plate is a cartilage structure at the end of long bones which mediates growth in children. When fractured, the formation of bony repair tissue known as a “bony bar” can occur and cause limb deformities. There are currently no effective clinical solutions for the prevention of the bony bar formation or regeneration of healthy growth plate cartilage after a fracture. This study employs previously developed alginate/chitosan polyelectrolyte complex (PEC) hydrogels as a sustained release vehicle for the delivery of short‐interfering RNA (siRNA). Specifically, the siRNA targets the p38‐MAPK pathway in mesenchymal stem cells (MSCs) to prevent their osteogenic differentiation. In vitro experimental findings show sustained release of siRNA from the hydrogels for 6 months. Flow cytometry and confocal imaging indicate that the hydrogels release siRNA to effectively knockdown GFP expression over a sustained period. MAPK‐14 targeting siRNA was used to knockdown the expression of MAPK‐14 and correspondingly decrease the expression of other osteogenic genes in MSCs in vitro over the span of 21 days. These hydrogels were used in a rat model of growth plate injury to determine whether siMAPK‐14 released from the gels could inhibit bony bar formation. No significant reduction of bony bar formation was seen in vivo at the one concentration of siRNA examined. This PEC hydrogel represents a significant advancement for siRNA sustained delivery, and presents an interesting potential therapeutic delivery system for growth plate injuries and other regenerative medicine applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quantitative Biosciences and Bioengineering, Colorado School of Mines, Golden, Colorado, USA.
- Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado, USA.
- Department of Orthopedics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Bikram Adhikari, Melissa D Krebs
Förderung
- NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Adhikari, B., Stager, M. A., Collins, E. G., Fischenich, K. M., Olusoji, J., Ruble, A. F., Payne, K. A., & Krebs, M. D. (2024). Sustained release of MAPK14 ‐targeting siRNA from polyelectrolyte complex hydrogels mitigates MSC osteogenesis in vitro with potential application in growth plate injury. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37784
Vancouver
Adhikari B, Stager MA, Collins EG, Fischenich KM, Olusoji J, Ruble AF, et al. Sustained release of MAPK14 ‐targeting siRNA from polyelectrolyte complex hydrogels mitigates MSC osteogenesis in vitro with potential application in growth plate injury. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37784
BibTeX
@article{Adhikari2024,
author = {Adhikari, Bikram and Stager, Michael A and Collins, Elise G and Fischenich, Kristine M and Olusoji, Jesutomisin and Ruble, Ana Ferreira and Payne, Karin A and Krebs, Melissa D},
title = {Sustained release of MAPK14 ‐targeting siRNA from polyelectrolyte complex hydrogels mitigates MSC osteogenesis in vitro with potential application in growth plate injury},
journal = {Journal of Biomedical Materials Research Part A},
year = {2024},
doi = {10.1002/jbm.a.37784}
}
EUVIMED